![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Chongqing Huapont Pharmaceutical Co., Ltd. Chongqing Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Isotretinoin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-330 - Rev 00
This Chemical Type CEP, issued on October 13, 2016, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1019 associated with this CEP further emphasizes